{"name":"HealthCare Ventures","permalink":"healthcare-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/healthcare-ventures","homepage_url":"http://www.hcven.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617.252.4343","description":"Venture capital Firm","email_address":"rsteinberg@hcven.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Jun 16 16:28:54 UTC 2009","updated_at":"Thu Jun 18 02:30:16 UTC 2009","overview":"<p>HealthCare Ventures is a leading venture capital firm specializing in life science industry investing. At HealthCare Ventures we concentrate our investment dollars on life science companies showing high growth potential. Since 1985, we have maintained a constant objective to support entrepreneurs and to generate above average returns for our limited partners.</p>","image":{"available_sizes":[[[150,20],"assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],[[250,34],"assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],[[290,40],"assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"55 Cambridge Parkway","address2":"Suite 301","zip_code":"02142-1234","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":42.3659479,"longitude":-71.0752083},{"description":"","address1":"44 Nassau Street","address2":"","zip_code":"08542-4511","city":"Princeton","state_code":"NJ","country_code":"USA","latitude":40.349555,"longitude":-74.661765}],"relationships":[{"is_past":false,"title":"Managing Director and Co-founder","person":{"first_name":"Harold","last_name":"R. Werner","permalink":"harold-r-werner","image":null}},{"is_past":false,"title":"Managing Director","person":{"first_name":"James","last_name":"H. Cavanaugh","permalink":"james-h-cavanaugh","image":null}},{"is_past":false,"title":" Managing Partner","person":{"first_name":"Augustine","last_name":"Lawlor","permalink":"augustine-lawlor","image":null}}],"investments":[{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/vaxinnate-corp-series-d-30m/","source_description":"VaxInnate Corp., Series D $30M ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":14,"company":{"name":"VaxInnate","permalink":"vaxinnate","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/8849/48849v1-max-150x150.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-250x250.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.trevenainc.com/news/index/trevena_announces_24_million_series_a_financing/","source_description":"Trevena, Inc. Announces $24 Million Series A Financing","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":1,"company":{"name":"Trevena","permalink":"trevena","image":{"available_sizes":[[[135,79],"assets/images/resized/0004/9263/49263v1-max-150x150.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-250x250.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.masshightech.com/stories/2009/03/09/daily15-Seahorse-Bioscience-lands-6M-buys-BioProcessors-Corp.html","source_description":"Seahorse Bioscience lands $6M, buys BioProcessors Corp","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":9,"company":{"name":"Seahorse Bioscience","permalink":"seahorse-bioscience","image":{"available_sizes":[[[150,33],"assets/images/resized/0004/9829/49829v1-max-150x150.jpg"],[[250,56],"assets/images/resized/0004/9829/49829v1-max-250x250.jpg"],[[287,65],"assets/images/resized/0004/9829/49829v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.reuters.com/article/idUS91076+25-Aug-2008+BW20080825","source_description":"Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":25,"company":{"name":"Proteostasis Therapeutics","permalink":"proteostasis-therapeutics","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/0038/50038v2-max-150x150.png"],[[250,77],"assets/images/resized/0005/0038/50038v2-max-250x250.png"],[[374,116],"assets/images/resized/0005/0038/50038v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/xanodyne-pharmaceuticals-inc-series-d-38m/","source_description":"Xanodyne Pharmaceuticals, Inc.: Series D $38M","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":23,"company":{"name":"Xanodyne","permalink":"xanodyne","image":{"available_sizes":[[[150,49],"assets/images/resized/0005/0368/50368v1-max-150x150.png"],[[250,83],"assets/images/resized/0005/0368/50368v1-max-250x250.png"],[[286,95],"assets/images/resized/0005/0368/50368v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/press-releases/catalyst-biosciences-raises-40-million-series-c-financing?utm_medium=nl&utm_source=internal&cmp-id=EMC-NL-FB&dest=FB","source_description":"Catalyst Biosciences Raises $40 Million in Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":3,"company":{"name":"Catalyst Biosciences","permalink":"catalyst-biosciences","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/0378/50378v1-max-150x150.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-250x250.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-newsArticle&ID=1312215&highlight=","source_description":"PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants","raised_amount":19300000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":27,"company":{"name":"PharmAthene","permalink":"pharmathene","image":{"available_sizes":[[[150,49],"assets/images/resized/0006/0993/60993v1-max-150x150.jpg"],[[223,73],"assets/images/resized/0006/0993/60993v1-max-250x250.jpg"],[[223,73],"assets/images/resized/0006/0993/60993v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"debt_round","source_url":"http://www.masshightech.com/stories/2009/11/23/daily31-Stemgent-issues-notes-to-raise-27M.html","source_description":"Stemgent issues notes to raise $2.7M","raised_amount":2700000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":25,"company":{"name":"Stemgent","permalink":"stemgent","image":{"available_sizes":[[[150,30],"assets/images/resized/0004/1138/41138v1-max-150x150.png"],[[250,50],"assets/images/resized/0004/1138/41138v1-max-250x250.png"],[[310,63],"assets/images/resized/0004/1138/41138v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/seahorse-bioscience-inc-series-d-5m/","source_description":"Seahorse Bioscience, Inc.: Series D $5M ","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":8,"company":{"name":"Seahorse Bioscience","permalink":"seahorse-bioscience","image":{"available_sizes":[[[150,33],"assets/images/resized/0004/9829/49829v1-max-150x150.jpg"],[[250,56],"assets/images/resized/0004/9829/49829v1-max-250x250.jpg"],[[287,65],"assets/images/resized/0004/9829/49829v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.radiuspharm.com/Radius2ndFinancing.pdf","source_description":"Radius Raises $57.5 Million in Second Private Financing Round","raised_amount":57500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":2,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/node/5164","source_description":"Sequoia Pharmaceuticals Raises $35M In Series C Financing","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":9,"company":{"name":"Sequoia Pharmaceuticals","permalink":"sequoia-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0007/9955/79955v1-max-150x150.jpg"],[[204,62],"assets/images/resized/0007/9955/79955v1-max-250x250.jpg"],[[204,62],"assets/images/resized/0007/9955/79955v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.venturedeal.com/News/2007/11/5/Ascent-Therapeutics-Secures-$8-Million-Series-A","source_description":"Ascent Therapeutics Secures $8 Million Series A","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":5,"company":{"name":"Ascent Therapeutics","permalink":"ascent-therapeutics","image":{"available_sizes":[[[150,79],"assets/images/resized/0008/0481/80481v1-max-150x150.jpg"],[[214,113],"assets/images/resized/0008/0481/80481v1-max-250x250.jpg"],[[214,113],"assets/images/resized/0008/0481/80481v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.freshnews.com/news/62624/mountain-view-avidia-raises-438-million-advance-new-class-pharmaceuticals","source_description":"AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS","raised_amount":43800000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":9,"company":{"name":"Avidia","permalink":"avidia","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://www.thefreelibrary.com/VaxInnate+Secures+$40+Million+Series+C+Financing-a0153993028","source_description":"VaxInnate Secures $40 Million Series C Financing.","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":10,"funded_day":25,"company":{"name":"VaxInnate","permalink":"vaxinnate","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/8849/48849v1-max-150x150.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-250x250.png"],[[178,44],"assets/images/resized/0004/8849/48849v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.catalystbiosciences.com/news-pr-seriesb.html","source_description":"CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":2,"funded_day":9,"company":{"name":"Catalyst Biosciences","permalink":"catalyst-biosciences","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/0378/50378v1-max-150x150.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-250x250.png"],[[173,110],"assets/images/resized/0005/0378/50378v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Cap Funding Report","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":24,"company":{"name":"Promedior","permalink":"promedior","image":{"available_sizes":[[[150,93],"assets/images/resized/0008/0744/80744v2-max-150x150.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-250x250.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/foldrx-banks-29m-neurodegenerative-drug-application/2010-06-15?utm_medium=rss&utm_source=rss","source_description":"FoldRx banks $29M for neurodegenerative drug application","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":15,"company":{"name":"Foldrx Pharmaceuticals","permalink":"foldrx-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://articleyoube.com/file/91c5oi935300051r7a/x1u3n148908","source_description":"Sequoia Pharmaceuticals Secures Funding to Test its Unique AIDS Drug","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":3,"funded_day":20,"company":{"name":"Sequoia Pharmaceuticals","permalink":"sequoia-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0007/9955/79955v1-max-150x150.jpg"],[[204,62],"assets/images/resized/0007/9955/79955v1-max-250x250.jpg"],[[204,62],"assets/images/resized/0007/9955/79955v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/trevena-inc-series-b-35m/","source_description":"Trevena, Inc.: Series B $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":14,"company":{"name":"Trevena","permalink":"trevena","image":{"available_sizes":[[[135,79],"assets/images/resized/0004/9263/49263v1-max-150x150.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-250x250.jpg"],[[135,79],"assets/images/resized/0004/9263/49263v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/stemgent-inc-series-b-56m/","source_description":"Stemgent, Inc.: Series B $5.6M","raised_amount":5600000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":19,"company":{"name":"Stemgent","permalink":"stemgent","image":{"available_sizes":[[[150,30],"assets/images/resized/0004/1138/41138v1-max-150x150.png"],[[250,50],"assets/images/resized/0004/1138/41138v1-max-250x250.png"],[[310,63],"assets/images/resized/0004/1138/41138v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xconomy.com/seattle/2010/03/19/theraclone-raises-1-5m/","source_description":"Theraclone Raises $1.5M","raised_amount":1500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Theraclone Sciences","permalink":"theraclone-sciences","image":{"available_sizes":[[[150,32],"assets/images/resized/0009/4651/94651v1-max-150x150.jpg"],[[250,54],"assets/images/resized/0009/4651/94651v1-max-250x250.jpg"],[[305,67],"assets/images/resized/0009/4651/94651v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetralogic-nabs-32m-round-lead-cancer-therapy/2010-08-10?utm_medium=rss&utm_source=rss","source_description":"TetraLogic nabs $32M round for lead cancer therapy  Read more: TetraLogic nabs $32M round for lead cancer therapy","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":10,"company":{"name":"TetraLogic Pharmaceuticals","permalink":"tetralogic-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8561/98561v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/8561/98561v1-max-250x250.png"],[[270,78],"assets/images/resized/0009/8561/98561v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.anchortx.com/news-events/pr-AnchorSecures10MillionSeriesB082010.php","source_description":"Anchor Therapeutics Secures $10 Million Series B Financing to Advance Pepducin Drug Candidates","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":20,"company":{"name":"Anchor Therapeutics","permalink":"anchor-therapeutics","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8740/98740v1-max-150x150.jpg"],[[250,73],"assets/images/resized/0009/8740/98740v1-max-250x250.jpg"],[[400,117],"assets/images/resized/0009/8740/98740v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.masshightech.com/stories/2010/10/18/daily46-Dicerna-makes-29M-second-close-on-Series-B-funding-round.html","source_description":"Dicerna makes $29M second close on Series B funding round","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":21,"company":{"name":"Dicerna Pharmaceuticals","permalink":"dicerna-pharmaceuticals","image":{"available_sizes":[[[150,56],"assets/images/resized/0007/2125/72125v1-max-150x150.jpg"],[[227,86],"assets/images/resized/0007/2125/72125v1-max-250x250.jpg"],[[227,86],"assets/images/resized/0007/2125/72125v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2010/09/decimmune-therapeutics-receives-1m-in.html","source_description":"DecImmune Therapeutics Receives $1M in Equity Financing; $2.2M Phase II SBIR Funding","raised_amount":3200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":27,"company":{"name":"DecImmune Therapeutics","permalink":"decimmune-therapeutics","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.cellnovo.com/CellnovoPressReleaseSeries.pdf","source_description":"CELLNOVO SECURES Â£30 MILLION IN SERIES B FINANCING","raised_amount":30000000,"raised_currency_code":"GBP","funded_year":2011,"funded_month":2,"funded_day":4,"company":{"name":"CellNovo","permalink":"cellnovo","image":{"available_sizes":[[[149,48],"assets/images/resized/0012/0629/120629v1-max-150x150.png"],[[149,48],"assets/images/resized/0012/0629/120629v1-max-250x250.png"],[[149,48],"assets/images/resized/0012/0629/120629v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://ca.finance.yahoo.com/news/nanoMR-Announces-13-Million-bw-2900517672.html?x=0","source_description":"nanoMR Announces $13 Million Series B Financing","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":19,"company":{"name":"nanoMR","permalink":"nanomr","image":{"available_sizes":[[[150,58],"assets/images/resized/0014/5097/145097v1-max-150x150.jpg"],[[176,69],"assets/images/resized/0014/5097/145097v1-max-250x250.jpg"],[[176,69],"assets/images/resized/0014/5097/145097v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/radius-health-inc-series-c-66m/","source_description":"Radius Health, Inc.: Series C $66M","raised_amount":66000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":26,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://pathogenetix.com/index.php?option=com_content&task=view&id=257&Itemid=2","source_description":"PathoGenetiX Inc. completes first close of Series B Financing ... ","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":1,"company":{"name":"Pathogenetix","permalink":"pathogenetix","image":{"available_sizes":[[[150,50],"assets/images/resized/0007/4248/74248v2-max-150x150.png"],[[250,84],"assets/images/resized/0007/4248/74248v2-max-250x250.png"],[[323,109],"assets/images/resized/0007/4248/74248v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/08/cleveland-heartlab-completes-18-4m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cleveland HeartLab Completes $18.4M Series B Financing Round","raised_amount":18400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":22,"company":{"name":"Cleveland HeartLab","permalink":"cleveland-heartlab","image":{"available_sizes":[[[150,20],"assets/images/resized/0015/0625/150625v1-max-150x150.png"],[[250,34],"assets/images/resized/0015/0625/150625v1-max-250x250.png"],[[360,49],"assets/images/resized/0015/0625/150625v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/09/tensha-therapeutics-raises-15m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Tensha Therapeutics Raises $15M in Series A Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":12,"company":{"name":"Tensha Therapeutics","permalink":"tensha-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0015/3875/153875v1-max-150x150.png"],[[161,53],"assets/images/resized/0015/3875/153875v1-max-250x250.png"],[[161,53],"assets/images/resized/0015/3875/153875v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.masshightech.com/stories/2011/10/31/daily18-PathoGenetix-adds-75M-to-Series-B-funding.html","source_description":"PathoGenetix adds $7.5M to Series B funding","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":1,"company":{"name":"Pathogenetix","permalink":"pathogenetix","image":{"available_sizes":[[[150,50],"assets/images/resized/0007/4248/74248v2-max-150x150.png"],[[250,84],"assets/images/resized/0007/4248/74248v2-max-250x250.png"],[[323,109],"assets/images/resized/0007/4248/74248v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.pr-inside.com/sensors-for-medicine-and-science-raises-r2883468.htm","source_description":"Sensors for Medicine and Science Raises $54.1 Million Series D Financing","raised_amount":54100000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":1,"company":{"name":"Sensors for Medicine and Science","permalink":"sensors-for-medicine-and-science","image":{"available_sizes":[[[150,40],"assets/images/resized/0016/0502/160502v1-max-150x150.jpg"],[[213,57],"assets/images/resized/0016/0502/160502v1-max-250x250.jpg"],[[213,57],"assets/images/resized/0016/0502/160502v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/mosaic-biosciences-inc-series-a-1m/","source_description":"Mosaic Biosciences, Inc.: Series A $1M","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":8,"company":{"name":"Mosaic Biosciences","permalink":"mosaic-biosciences","image":{"available_sizes":[[[150,43],"assets/images/resized/0014/5732/145732v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0014/5732/145732v1-max-250x250.jpg"],[[311,90],"assets/images/resized/0014/5732/145732v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://radiuspharm.mwnewsroom.com/getattachment/6bc08185-9982-4ca1-8016-ab824b0ed0d7/Radius-Raises-Additional-$15-Million,-Increasing-S","source_description":"Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":20,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/radius-health-inc-series-c-214m/","source_description":"Radius Health, Inc.: Series C $21.4M","raised_amount":21400000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":13,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.fiercebiotech.com/story/promedior-lands-215m-d-round-fibrosis-pipeline/2012-03-07?utm_medium=rss&utm_source=rss","source_description":"Promedior lands $21.5M D round for fibrosis pipeline","raised_amount":21500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":7,"company":{"name":"Promedior","permalink":"promedior","image":{"available_sizes":[[[150,93],"assets/images/resized/0008/0744/80744v2-max-150x150.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-250x250.jpg"],[[162,101],"assets/images/resized/0008/0744/80744v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.masshightech.com/stories/2012/06/11/daily21-GITR-gets-1M-from-HealthCare-Ventures.html","source_description":"GITR gets $1M from HealthCare Ventures","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":12,"company":{"name":"GITR","permalink":"gitr","image":null}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}